» Articles » PMID: 28940091

Use of a Commercially Available Microarray to Characterize Antibiotic-Resistant Clinical Isolates of Klebsiella Pneumoniae

Overview
Journal Curr Microbiol
Specialty Microbiology
Date 2017 Sep 24
PMID 28940091
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A commercially available microarray (IDENTIBAC AMR-ve) for the detection of antibiotic resistance determinants was investigated for its potential to genotype 30 clinical isolates and two control strains of Klebsiella pneumoniae. Resistance profiles and the production of extended-spectrum β-lactamases were determined by disc diffusion and the results were compared with the microarray profiles in order to assess its scope and limitations. Genes associated with resistance to a wide range of antibiotics, including current first line therapy options, were detected. In addition, the array also detected class 1 integrases. The array is easy to use and interpret, and is useful in providing a general description of the numbers and types of resistance determinants in K. pneumoniae. It also provides an indication of the potential for resistance gene acquisition. However, in most instances detected resistance to specific antibiotics could not unequivocally be assigned to hybridization with a specific array probe. We conclude that the microarray is a valuable and rapid means of investigating the presence of resistance gene classes of therapeutic importance. It can also provide a starting point for selecting analyses of greater resolving power, such as phylogenetic subtyping by PCR sequencing.

Citing Articles

A magnetic epitope-imprinted microsphere used for selective separation and rapid detection of SHV-type β-lactamases in bacteria: a novel strategy of antimicrobial resistance detection.

Zhou Y, Wang K, Li L, Li H, Tian Q, Ge B J Nanobiotechnology. 2024; 22(1):678.

PMID: 39501279 PMC: 11539605. DOI: 10.1186/s12951-024-02949-9.


Multiplex Microarrays in 96-Well Plates Photoactivated with 4-Azidotetrafluorobenzaldehyde for the Identification and Quantification of β-Lactamase Genes and Their RNA Transcripts.

Ulyashova M, Presnova G, Filippova A, Grigorenko V, Egorov A, Rubtsova M Curr Issues Mol Biol. 2024; 46(1):53-66.

PMID: 38275665 PMC: 10814224. DOI: 10.3390/cimb46010005.


Recent Developments in Electrochemical Sensors for the Detection of Antibiotic-Resistant Bacteria.

Madhu S, Ramasamy S, Choi J Pharmaceuticals (Basel). 2022; 15(12).

PMID: 36558939 PMC: 9786047. DOI: 10.3390/ph15121488.


Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods.

Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Culafic D Antibiotics (Basel). 2022; 11(4).

PMID: 35453179 PMC: 9024665. DOI: 10.3390/antibiotics11040427.

References
1.
Bhattacharjee A, SEN M, Prakash P, Gaur A, Anupurba S, Nath G . Observation on integron carriage among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Indian J Med Microbiol. 2010; 28(3):207-10. DOI: 10.4103/0255-0857.66472. View

2.
Schwaber M, Carmeli Y . Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA. 2008; 300(24):2911-3. DOI: 10.1001/jama.2008.896. View

3.
Babini G, Livermore D . Are SHV beta-lactamases universal in Klebsiella pneumoniae?. Antimicrob Agents Chemother. 2000; 44(8):2230. PMC: 90049. DOI: 10.1128/AAC.44.8.2230-2230.2000. View

4.
Miller G, Sabatelli F, Hare R, Glupczynski Y, Mackey P, Shlaes D . The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis. 1997; 24 Suppl 1:S46-62. DOI: 10.1093/clinids/24.supplement_1.s46. View

5.
Almaghrabi R, Clancy C, Doi Y, Hao B, Chen L, Shields R . Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. Antimicrob Agents Chemother. 2014; 58(8):4443-51. PMC: 4135979. DOI: 10.1128/AAC.00099-14. View